Fbxw11 was expressed at lower levels in patients with ALL who achieved complete remission (CR), although the difference was not statistically significant due to the limited number of cases and heterogeneity among patients (Fig. 1d). The gene discussed is FBXW11; the disease is acute lymphoblastic leukemia.